A Novel Oxidative Stress-Related lncRNA Signature That Predicts the Prognosis and Tumor Immune Microenvironment of Breast Cancer

Table 3

Clinical impacts of the risk score characteristics (as identified by the TCGA-COAD data).

Clinical		Mean	SD
Risk score
Age
>65	222	2.064	2.442	1.378	0.169
≤65	634	1.805	2.304
Gender
Female	845	1.878	2.354	1.322	0.212
Male	11	1.465	1.001
Stage
I-II	655	1.708	2.169	-3.282	0.001
III-IV	201	2.408	2.773
T
T1-2	734	1.794	2.21	-1.938	0.055
T3-4	122	2.342	2.987
M
M0	840	1.851	2.323	-1.504	0.153
M1	16	3.014	3.076
N
N0	420	1.661	2.087	-2.605	0.009
N1-3	436	2.076	2.55